L

Labgenomics Co Ltd
KOSDAQ:084650

Watchlist Manager
Labgenomics Co Ltd
KOSDAQ:084650
Watchlist
Price: 2 455 KRW 0.2% Market Closed
Market Cap: 182.3B KRW
Have any thoughts about
Labgenomics Co Ltd?
Write Note

Net Margin
Labgenomics Co Ltd

-26%
Current
15%
Average
-7.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-26%
=
Net Income
-22.3B
/
Revenue
85.8B

Net Margin Across Competitors

Country Company Market Cap Net
Margin
KR
Labgenomics Co Ltd
KOSDAQ:084650
182.3B KRW
-26%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-21 040%
US
Abbvie Inc
NYSE:ABBV
310.3B USD
9%
US
Amgen Inc
NASDAQ:AMGN
141.6B USD
13%
US
Gilead Sciences Inc
NASDAQ:GILD
115.3B USD
0%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
102.4B USD
-5%
US
Epizyme Inc
F:EPE
94.1B EUR
-392%
AU
CSL Ltd
ASX:CSL
134.4B AUD
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.3B USD
34%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
35.8B EUR
-14%
Country KR
Market Cap 182.3B KRW
Net Margin
-26%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 310.3B USD
Net Margin
9%
Country US
Market Cap 141.6B USD
Net Margin
13%
Country US
Market Cap 115.3B USD
Net Margin
0%
Country US
Market Cap 102.4B USD
Net Margin
-5%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 134.4B AUD
Net Margin
18%
Country US
Market Cap 77.3B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 35.8B EUR
Net Margin
-14%
No Stocks Found

Labgenomics Co Ltd
Glance View

Market Cap
182.3B KRW
Industry
Biotechnology

LabGenomics Co., Ltd. engages in the provision of vitro diagnostic products and services. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2013-07-01. The firm mainly provides IVD services, including general diagnostic check services, molecular diagnostic check services, and research and development services. The Company’s IVD products include deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) kits and others. The company also provides examination for breast cancer and colorectal cancer, biosensor for point of care testing (POCT) and others. The company also provides healthy food.

Intrinsic Value
2 727.2 KRW
Undervaluation 10%
Intrinsic Value
Price
L

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-26%
=
Net Income
-22.3B
/
Revenue
85.8B
What is the Net Margin of Labgenomics Co Ltd?

Based on Labgenomics Co Ltd's most recent financial statements, the company has Net Margin of -26%.